Tag: Women’s Health
-
Northwestern Medicine Scientists Lead Project to Develop Novel Female Contraceptives
A multi-institution team of investigators led by Northwestern Medicine scientists has received an $8 million grant for the identification of novel biological targets to develop non-hormonal contraceptives for women in developing countries.
-
Targeting Proteins May Help Eliminate Radioresistant Breast Cancer Cells
Targeting the proteins CD47 and HER2 may eliminate radioresistant breast cancer cells and enable more effective radiotherapy treatments for patients, according to a new study.
-
Grobman Elected to National Academy of Medicine
William Grobman, MD, MBA, ’97 ’00 GME, vice chair for clinical operations and the Arthur Hale Curtis, MD, Professor of Obstetrics and Gynecology, has been elected to the National Academy of Medicine.
-
Drug May Delay Progression of Ovarian Cancer
The drug rucaparib significantly delayed cancer progression for women with ovarian cancer and may be an effective option for maintenance therapy, according to findings from a recent clinical trial.
-
Biological Sex Affects Genes for Body Fat, Cancer, Birth Weight
Biological sex has a small but ubiquitous influence on gene expression in almost every type of human tissue, according to a new study.
-
New Therapy Targets Breast Cancer Metastases in Brain
A new combination therapy targeting breast cancer tumors in the brain dramatically decreased tumor size and increased survival in mice, according to a new study.
-
Support Tool Aims to Streamline Decision Process for Cesarean Delivery
A new patient-centered decision support tool aims to help pregnant women decide whether they prefer trial-of-labor or a repeat cesarean delivery after having a prior cesarean.
-
Strategies for Evaluating Breast Cancer with Machine Learning
Machine-learning technology could help pathologists more accurately assess how a patient’s immune system is responding to breast cancer, according to a recent series of reports authored in part by Feinberg faculty.
-
Chemotherapy for Early Stage Breast Cancer Associated with Greater Cognitive Impairment
In women with early-stage breast cancer, Northwestern Medicine investigators found chemoendocrine therapy was associated with greater cognitive impairment at three and six months compared to endocrine therapy alone.
-
Investigating the Genetic Mechanisms Behind Uterine Fibroids
A recent Northwestern Medicine study has identified that a transcription factor protein called AP-1 regulates gene enhancers that may be responsible for promoting the development of uterine fibroids.
